FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Dec 3, 2009
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on December 3, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- December 3, 2009
- Product Type
- Biologics
View Company Profile
ID · 2004491a-3045-4814-9956-4965b26740d6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 633306
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 6, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 21, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 3, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 1, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 9, 2017 | Not classified | Atlanta District Office |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1292178 - 2025-11-06
- FDA Inspection 1215163 - 2023-07-21
- FDA Inspection 1099074 - 2019-07-03
- FDA Inspection 1083437 - 2019-03-01
- FDA Inspection 1016091 - 2017-06-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.